NEWS & EVENTS

Tristel Webinar – Thursday 23rd Feb 12.15pm

The management of Tristel (AIM:TSTL), the manufacturer of infection control, contamination control and hygiene products, would like to invite you …

READ MORE

Benchmark Holdings Webinar – Thursday 26th Jan, 11.45am

The management of Benchmark Holdings (AIM:BMK), the pioneering innovation company operating in the aquaculture, agriculture and animal health sectors, would …

READ MORE

Investor Forum, 25th January 2017: Kromek, Ergomed & Realm Therapeutics

We will be hosting our next Investor Forum at Fladgate (please note the new venue) on the evening of Wednesday …

READ MORE
READ MORE NEWS & EVENTS

TWEETS

$IDOX.L AGM update from Chairman: ''strong start to year, current trading in-line with our expectations...solid pipeline of opportunities''

Fed minutes vague on rate rises: $ easier and Nikkei -1/2 % overnight. Not just German bonds firm, US too. UK shares to open slightly lower.

$TSTL @TristelGlobal Today's CEO & FD WEBINAR now Available for REPLAY: CLICK HERE TO ACCESS https://t.co/VDL16QlHHr

$TSTL @TristelGlobal Upbeat WEBINAR just finished. Co "confident" of US business in year to June '19. Shares now up 10% at 167p

$KMK @kromekgroup Read Wednesday's update note post $KMK's £21m fund raise close. ACCESS THE FULL NOTE HERE: https://t.co/ZSvT3itDyr

$PEB.L strategic review, seeks potential buyers for PBS software; xG paying $3m of VCS consideration early to satisfy VCS trade creditors

FOLLOW US ON TWITTER

WHY CHOOSE ED

"We cannot thank you enough for opening our eyes to private investors."

Liz Dixon
Tristel

MORE REASONS

"One of the biggest problems private investors have, is getting access to broker research. It’s basically impossible for many investors. Therefore I feel some commissioned research is really important and a good investment for companies. In my experience ED are far more proactive than other firms in this space."

Paul Scott
Blogger and Stockopedia Contributor

MORE REASONS

"From early days as a private company through to being established on AIM, I have always been able to rely on ED for wise counsel, perceptive research and introductions to new, supportive shareholders."

Arnab Basu
Kromek

MORE REASONS

"The team at ED consistently produce high quality research and highlight profitable investment opportunities, an invaluable tool for small cap investors in this under researched space."

Simon Thompson
Investors Chronicle

MORE REASONS